Table 1.
Risk Factorsa | Colonoscopy and/or Sigmoidoscopy (N=2131) |
FOBT (N=2131) |
Mammography (N=1156) |
Cervical Cytology (N=5068) |
||||
---|---|---|---|---|---|---|---|---|
0 | ≥ 1 | 0 | ≥ 1 | 0 | ≥ 1 | 0 | ≥ 1 | |
Social Risk Group | ||||||||
Group 1 (fewest risks) | 366 (24%) | 186 (30%) | 472 (26%) | 80 (23%) | 101 (26%) | 249 (32%) | 959 (45%) | 1437 (49%) |
Group 2 | 254 (17%) | 101 (16%) | 303 (17%) | 52 (15%) | 84 (22%) | 143 (19%) | 479 (23%) | 711 (24%) |
Group 3 | 677 (45%) | 283 (45%) | 794 (45%) | 166 (48%) | 155 (40%) | 304 (40%) | 501 (24%) | 609 (21%) |
Group 4 (most risks) | 211 (14%) | 53 (9%) | 214 (12%) | 50 (14%) | 48 (12%) | 72 (9%) | 186 (9%) | 186 (6%) |
Ageb | ||||||||
20 – 29 years old | - | - | - | - | - | - | 685 (32%) | 1333 (45%) |
30 – 39 years old | - | - | - | - | - | - | 482 (23%) | 697 (24%) |
40 – 49 years old | - | - | - | - | - | - | 377 (18%) | 416 (14%) |
>=50 (50-54 years old) | 695 (46%) | 285 (46%) | 803 (45%) | 177 (51%) | 171 (44%) | 359 (47%) | 581 (27%) | 497 (17%) |
>=50 (55-59 years old) | 578 (38%) | 259 (42%) | 711 (40%) | 126 (36%) | 152 (39%) | 298 (39%) | ||
>=50 (60-62 years old) | 235 (16%) | 79 (13%) | 269 (15%) | 45 (13%) | 65 (17%) | 111 (14%) | ||
Sex | ||||||||
Male | 738 (49%) | 242 (39%) | 821 (46%) | 159 (46%) | - | - | - | - |
Female | 770 (51%) | 381 (61%) | 962 (54%) | 189 (54%) | 388 (100%) | 768 (100%) | 2125 (100%) | 2943 (100%) |
Medicaid Coverage During Study Period | ||||||||
< 4 years | 475 (32%) | 145 (23%) | 544 (31%) | 76 (22%) | 144 (37%) | 155 (20%) | 738 (35%) | 729 (25%) |
4 years | 1033 (69%) | 478 (77%) | 1239 (69%) | 272 (78%) | 244 (63%) | 613 (80%) | 1387 (65%) | 2214 (75%) |
Regular Medical Provider | ||||||||
No | 278 (18%) | 52 (8%) | 286 (16%) | 44 (13%) | 57 (15%) | 57 (7%) | 404 (19%) | 480 (16%) |
Yes | 1223 (81%) | 569 (91%) | 1490 (84%) | 302 (87%) | 329 (85%) | 708 (92%) | 1713 (81%) | 2452 (83%) |
Adjusted Clinical Groups | ||||||||
1st quartile (healthiest) | 182 (12%) | 51 (8%) | 203 (11%) | 30 (9%) | 47 (12%) | 64 (8%) | 511 (24%) | 681 (23%) |
2nd quartile | 253 (17%) | 103 (17%) | 295 (17%) | 61 (18%) | 51 (13%) | 146 (19%) | 547 (26%) | 833 (28%) |
3rd quartile | 353 (23%) | 176 (28%) | 423 (24%) | 106 (30%) | 97 (25%) | 223 (29%) | 541 (25%) | 831 (28%) |
4th quartile (sickest) | 720 (48%) | 293 (47%) | 862 (48%) | 151 (43%) | 193 (50%) | 335 (44%) | 526 (25%) | 598 (20%) |
Area Deprivation Indexc | ||||||||
1st quartile (least) | 405 (27%) | 152 (24%) | 458 (26%) | 99 (28%) | 93 (24%) | 184 (24%) | 437 (21%) | 647 (22%) |
2nd quartile | 365 (24%) | 151 (24%) | 430 (24%) | 86 (25%) | 95 (24%) | 154 (20%) | 517 (24%) | 627 (21%) |
3rd quartile | 323 (21%) | 152 (24%) | 399 (22%) | 76 (22%) | 84 (22%) | 199 (26%) | 563 (26%) | 787 (27%) |
4th quartile (most) | 335 (22%) | 140 (22%) | 404 (23%) | 71 (20%) | 90 (23%) | 193 (25%) | 525 (25%) | 780 (27%) |
Boldface indicates statistical significance (p < 0.05) between each risk factor and the receipt of the specific cancer screening test.
Age measured 2 years prior to study enrollment.
Area Deprivation Index (ADI) missing for 4-6% depending on specific preventive service test.